IL326970A - תכשירי רוקחות המכילים ניפוקלימאב - Google Patents

תכשירי רוקחות המכילים ניפוקלימאב

Info

Publication number
IL326970A
IL326970A IL326970A IL32697026A IL326970A IL 326970 A IL326970 A IL 326970A IL 326970 A IL326970 A IL 326970A IL 32697026 A IL32697026 A IL 32697026A IL 326970 A IL326970 A IL 326970A
Authority
IL
Israel
Prior art keywords
nipocalimab
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL326970A
Other languages
English (en)
Original Assignee
Momenta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc
Publication of IL326970A publication Critical patent/IL326970A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL326970A 2023-09-11 2024-09-11 תכשירי רוקחות המכילים ניפוקלימאב IL326970A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363581914P 2023-09-11 2023-09-11
PCT/IB2024/058841 WO2025057086A2 (en) 2023-09-11 2024-09-11 Pharmaceutical compositions of fcrn antibodies

Publications (1)

Publication Number Publication Date
IL326970A true IL326970A (he) 2026-05-01

Family

ID=93119673

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326970A IL326970A (he) 2023-09-11 2024-09-11 תכשירי רוקחות המכילים ניפוקלימאב

Country Status (4)

Country Link
AU (1) AU2024341074A1 (he)
IL (1) IL326970A (he)
TW (1) TW202527982A (he)
WO (1) WO2025057086A2 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025186787A1 (en) * 2024-03-08 2025-09-12 Momenta Pharmaceuticals, Inc. Compositions and methods for treating fetal and neonatal alloimmune thrombocytopenia

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2284192A3 (en) 2002-11-08 2011-07-20 Ablynx N.V. Camelidae antibodies for sublingual administration
CN102958538A (zh) * 2010-05-03 2013-03-06 弗·哈夫曼-拉罗切有限公司 用于降低含有蛋白质的制剂的粘度的组合物和方法
GB201208370D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Antibodies
JP5986637B2 (ja) 2012-09-26 2016-09-06 テルモ株式会社 薬液投与装置
CA2934644C (en) 2013-12-24 2023-11-21 Argen-X N.V. Fcrn antagonists and methods of use
DK3590962T3 (da) 2014-10-23 2021-12-13 Singh Molecular Medicine Llc Enkeltdomæneantistoffer rettet mod intracellulære antigener
SG10202007232WA (en) 2015-01-30 2020-09-29 Momenta Pharmaceuticals Inc Fcrn antibodies and methods of use thereof
EP3723802A1 (en) 2017-12-13 2020-10-21 Momenta Pharmaceuticals, Inc. Fcrn antibodies and methods of use thereof
UA130214C2 (uk) 2018-07-20 2025-12-24 Момента Фармасьютикалз, Інк. Фармацевтична композиція антитіл проти fcrn
US20210299255A1 (en) * 2018-07-20 2021-09-30 Momenta Pharmaceuticals, Inc. Compositions of fcrn antibodies and methods of use thereof
MX2021005323A (es) 2018-11-06 2021-08-24 Immunovant Sciences Gmbh Metodos de tratar la oftalmopatía de graves mediante el uso de anticuerpos anti-fcrn.
CN114630678A (zh) * 2019-08-01 2022-06-14 詹森生物科技公司 FcRn抗体及其使用方法
WO2022098955A1 (en) * 2020-11-06 2022-05-12 Janssen Biotech, Inc. Fcrn antibodies and methods of use thereof
US20250009850A1 (en) * 2021-10-29 2025-01-09 Alteogen, Inc. Pharmaceutical composition comprising human hyaluronidase ph20 and drug

Also Published As

Publication number Publication date
WO2025057086A3 (en) 2025-04-24
TW202527982A (zh) 2025-07-16
WO2025057086A2 (en) 2025-03-20
AU2024341074A1 (en) 2026-04-16

Similar Documents

Publication Publication Date Title
GB202019241D0 (en) Pharmaceutical composition
IL300090A (he) תכשירי רוקחות המכילים venglustat
IL304290A (he) הרכב תרופות
IL327150A (he) תכשירים פרמצבטיים
IL314046A (he) תכשירים תרופתיים של ribociclib
GB202019335D0 (en) Pharmaceutical compositions
GB202208464D0 (en) Pharmaceutical composition
GB202104224D0 (en) Pharmaceutical composition
GB202102575D0 (en) Fixed-dose pharmaceutical compositions
GB202018068D0 (en) Pharmaceutical composition
GB202010340D0 (en) Pharmaceutical composition
IL320961A (he) תרכובות רפואיות של מילווקסיאן
IL326977A (he) הרכבים פרמצבטיים
GB202312055D0 (en) Pharmaceutical compositions
GB202217150D0 (en) New pharmaceutical compositions
GB202217146D0 (en) New pharmaceutical compositions
IL312071A (he) תכשירים תרופתיים
GB202316245D0 (en) Rapamycin-containing pharmaceutical composition
GB202013701D0 (en) Pharmaceutical compositions
GB202510527D0 (en) Pharmaceutical compositions
GB202507038D0 (en) Pharmaceutical compositions
GB202507034D0 (en) Pharmaceutical compositions
GB202504959D0 (en) Pharmaceutical compositions
GB202504962D0 (en) Pharmaceutical compositions
GB202416866D0 (en) Pharmaceutical compositions